The SLC18A2 gene helps nerve cells package chemical messengers like dopamine and serotonin into tiny sacs so they can be released at the right time. This gene plays an important role in movement, mood, and automatic body functions such as blood pressure, sweating, and digestion. If both copies do not work properly, a person may develop a rare inherited condition with low muscle tone, movement problems, delayed development, and body control symptoms linked to these brain chemicals.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes hold the directions for producing proteins, the parts of cells that do much of the work. Others mainly help determine when certain processes happen, where they take place, and how strongly they run. Taken together, genes influence how the body develops and works, and they can affect how you respond to food, stress, or medications. You can find more on this topic in the LearnHub.
Overview
SLC18A2Gene function
What if the gene works
The SLC18A2 gene helps nerve cells package chemical messengers such as dopamine, serotonin, and norepinephrine into tiny storage sacs. This lets the brain and nervous system store and release these signals in a controlled way.
Risk
What if the gene does not work
More disruptive variants in the SLC18A2 gene can cause a movement condition that often begins in infancy or childhood, with low muscle tone, delayed development, and parkinsonism or dystonia. Milder variants may lead to later onset or fewer symptoms.
Treatment
What does that mean for your treatment
No SLC18A2-specific treatment or drug choice guideline is currently established for pathogenic variants in the SLC18A2 gene. The SLC18A2 gene is being studied because its protein is the target of some movement disorder drugs, including tetrabenazine, deutetrabenazine, and valbenazine, but this does not yet define treatment for inherited SLC18A2-related conditions.
Conditions associated with SLC18A2
Gene function
What if the gene works
In day to day brain signaling, the SLC18A2 gene helps nerve cells and some hormone making cells store key chemical messengers. Its protein moves dopamine, serotonin, norepinephrine, and related signals into tiny sacs inside the cell. That storage step keeps these messengers ready until the cell needs them.
This gene loads dopamine, serotonin, norepinephrine, and similar messengers into tiny storage sacs called vesicles. Keeping them in vesicles lets cells hold a ready supply for the next signal.
Vesicles keep these messengers away from the main cell fluid, where they can be changed or broken down. This helps preserve them until the cell is ready to use them.
Filled vesicles can move to the cell surface and release their contents when a signal arrives. This supports orderly communication between nerve cells and some hormone making cells.
After release, cells can reuse or refill vesicles for later signals. This ongoing cycle helps brain and body signaling stay steady from moment to moment.
What is a variant?
A genetic variant is a small change in a gene’s DNA sequence. These changes are common and help shape normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC18A2 gene can alter the protein’s shape, stability, or placement in the cell, reducing how well it moves dopamine and related chemical messengers into small storage sacs inside nerve cells. Some SLC18A2 gene variants leave partial transporter activity, while more severe variants can nearly abolish it. This range in functional effect can influence whether SLC18A2-related movement and developmental features appear later and stay milder or begin earlier and affect more areas.
How variants are linked to conditions
Rare disease-causing variants in both copies of the SLC18A2 gene cause brain dopamine-serotonin vesicular transport disease, a rare inherited condition affecting movement and development. In practice, conditions linked to SLC18A2 gene variants include developmental delay, low muscle tone, feeding difficulty, and movement symptoms such as tremor, stiffness, or episodes of parkinsonism-dystonia. These rare inherited variants can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply contribute to natural differences between people. In many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences are involved. In other situations, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SLC18A2 gene. In families with a known disease-causing change, risk is mainly linked to the genetic change itself, and anyone with questions about personal or family risk should speak with a doctor or genetic counselor.
Inheritance of SLC18A2 variants
SLC18A2-related conditions are inherited in an autosomal recessive pattern. This means a person usually develops an SLC18A2-related condition only when they inherit one disease-causing variant in the SLC18A2 gene from each parent. Parents who each carry one variant are typically unaffected carriers, and with each pregnancy there is a 25% chance the child will inherit both variants, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. This autosomal recessive SLC18A2 inheritance pattern affects males and females equally.
What does my SLC18A2 result mean for my family?
For families with a disease-causing SLC18A2 result, the condition is passed down in a recessive pattern, so parents are often healthy carriers. Brothers and sisters may also be affected or may be carriers, and other relatives could carry the same change without knowing it. This can matter for family planning and for relatives who want to understand their own chances of being carriers.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for the SLC18A2 gene usually uses a blood or saliva sample. A lab reads the DNA sequence in the SLC18A2 gene to look for variants, often through a neurologic gene panel or a broader exome test. Results can show whether a variant is present and whether it may help explain symptoms or confirm an inherited diagnosis.
When should I consider getting a genetic test?
Genetic testing for the SLC18A2 gene may be considered if a baby or child has unexplained severe movement problems, low muscle tone, delayed development, or signs of a rare dopamine-related brain condition. It can also be relevant when a close family member has a confirmed SLC18A2 variant or the same pattern of symptoms.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals depends on the condition and the specific variant involved. How the body works over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles medicines, so the same treatment may work differently from one person to another. Some people process a drug more slowly or more quickly, while others may be more or less sensitive to its effects. These differences are common and can influence how well a medicine works or how likely side effects are. Medication response also reflects factors like age, other health conditions, and other medicines you take.
What is Pharmacogenetics?
Pharmacogenetics examines the way genetic differences shape a person’s response to medications. By studying links between genes and drugs, it helps explain why the same treatment can work differently in different people. With many medicines, genes can influence either how strong the drug’s effects are or how the body handles it. This information can support treatment decisions that are both more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the SLC18A2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so general medication questions are best discussed with your doctor or pharmacist. Seek medical advice if you have side effects, your treatment is not working as expected, or you are starting a new medicine and want to review how it fits with your overall health.
History
SLC18A2 entered modern genetics through neuroscience research on how brain chemicals are packaged inside nerve cells. In the 1990s, researchers identified and cloned the human SLC18A2 gene while tracing the protein long known as VMAT2. Initially understood only through drug studies, later recognized as tied to a specific gene, it became an important link between older pharmacology and modern molecular genetics. Building on this early work, scientists used SLC18A2 to study conditions affecting dopamine, serotonin, and related signaling pathways. The gene also gained research attention because brain imaging tools were developed to track VMAT2 in living people. These steps shaped today’s understanding of SLC18A2 as a well established marker in neurobiology research.